Sadao Kuromitsu

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 17, 2019
Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression.

Hiroaki Tanaka, Hideki Sakagami, Naoki Kaneko

Pageof 1

Frequent Collaborators

1 joint publications

Hiroyuki Koshio